ExpertiseUpdated on 4 May 2026
Global Medical Affairs Expertise Rare- Ultra-Rare Diseases.
Medicla & Clinical Affairs Expert at Makhankov Consulting
Rheinfelden, Switzerland
About
I build and lead Global & Regional Medical Affairs, Clinical Affairs, Real-World Evidence strategies in rare and ultra-rare diseases across complex, multi-country regions. Within global pharma 6 biotech and strategic advisory roles I operate at the intersection of science, access, compliance, and patient impact. My core mission is translating complex clinical data into actionable Global & Regional medical strategy that accelerates diagnosis, enables reimbursement, and ensures sustainable patient access. I have led pre-launch, launch and post-launch Medical Affairs programs across EMEA, CIS, Central Asia, Middle East/GCC, Africa, and LATAM. My focus spans rare neurology and neuromuscular disorders, genetic metabolic diseases, pulmonary hypertension, and cardiorespiratory conditions. I build medical ecosystems establishing KOL networks, supporting centers of excellence, driving registries and RWE programs, and aligning medical strategy with global and regional business priorities.
https://inferreconsult.com/makhankov-consulting/dr-yury-makhankov/
Field
- Biotech, Pharma and Cosmetics
- Healthcare
Organisation
Similar opportunities
Partnership
EMEA Commercial Partnership — AI-Powered Pharma Rep Training & HCP Engagement Simulation
Iwan Karlen
GM EMEA | Global Head of Strategy & Growth | ex-Novartis at Ascentium Talent
Basel, Switzerland
Expertise
- Other
- Healthcare
- Biotech, Pharma and Cosmetics
- Industrial Equipment and Machinery
Bernhard Bichsel
Co-CEO at ISS AG, Integrated Scientific Services
Bern, Switzerland